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Abstract Bacterial phosphotriesterases are enzymes that hy-
drolyse phosphotriester-containing organophosphate pesticides. 
Resiniferatoxin is a vanilloid that desensitises nociceptive 
neurons. By screening a rat cDNA library with labelled 
resiniferatoxin, we unexpectedly isolated a novel rat phospho-
triesterase homologue, here named rpr-1, that encodes a 349 
ammo acid, 39 kDa protein (confirmed by in vitro translation). 
Northern blotting and in situ hybridisation show expression 
primarily in proximal tubules of the kidney, in which rpr-1 
distribution correlates with resiniferatoxin-binding activity. 
These results suggest an unsuspected link between the phospho-
triesterase enzyme family and resiniferatoxin toxicity and 
pharmacology. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Microbial phosphotriesterases are a group of zinc metallo-
enzymes that catalyse the hydrolysis of a range of phospho-
triester compounds including organophosphate insecticides 
and nerve gases, for example parathion, paraoxon, sarin and 
soman. They have attracted much interest in recent years be-
cause of their promise as agents for detoxification of organo-
phosphate-contaminated industrial and agricultural waste [1] 
and because of their ability to protect against attack by orga-
nophosphate neurotoxins [2]. They have therefore been 
studied closely at the biochemical, molecular genetic and crys-
tallographic levels [3-7]. 
So far, all proteins with proven phosphotriesterase activity 
have been isolated from prokaryotic sources, but recently H o u 
et al. (1996) have isolated from mice a c D N A sequence with 
significant homology to Flavobacterium spp parathion hydro-
lase and the phosphotriesterases of Escherichia coli and 
Pseudomonas diminuta, particularly in the regions of the en-
zyme's active sites. The functions and possible enzyme activ-
ities of the protein encoded by this mouse gene, mpr56-l, have 
not yet been determined. 
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The sequence of rpr-1 has the EMBL accession number X99477. 
We have been studying clones from a rat c D N A expression 
library that have been selected for their ability to bind resin-
iferatoxin, a plant-derived vanilloid that desensitises certain 
nociceptive neurons and is therefore of great pharmacological 
interest [9-11]. The cDNAs of most of these resiniferatoxin-
binding clones represent m R N A s that are expressed in the 
nervous system [12,13]. One, however, was found to be ex-
pressed primarily in the kidney. Here, we report the sequence 
and expression pattern of this cDNA, rpr-1. Our results sug-
gest that rpr-1 is a resiniferatoxin-binding rat homologue of 
prokaryotic phosphotriesterases that is expressed primarily in 
proximal renal tubules. 
2. Materials and methods 
2.1. Isolation of Clone rpr-1 
The cone containing rpr-1, among others, was obtained by screen-
ing of a rat dorsal root ganglion (DRG) cDNA library with resin-
iferanol-9,13,14-orthophenylacetate-20- (3-azido, 4 methoxyphenyl) 
acetate (RTX-PAL [13]). A neonatal rat cDNA expression library 
was plated at 5X104 pfu/150 mm plate and after incubation for 3.5 
h at 42°C the plates were overlaid with Hibond-C membranes (Amer-
sham) impregnated with 10 mM IPTG for induction of protein ex-
pression, and incubated for a further 4 h at 37°C. Filters were incu-
bated in 10 nM RTX-PAL solution in PBS for 30 min at room 
temperature, washed briefly in PBS and UV-irradiated for 90 s. The 
filters were then washed in PBS, blocked with 5% haemoglobin (Sig-
ma) and incubated overnight at 4°C with rabbit polyclonal anti-RTX 
serum. After 3 washes in PBS, 50 mM Tris (pH 7.4) and finally 50 
mM Tris (pH 9.5), they were incubated for 15 min with Nitroblue 
tetrazolium and bromochloroindolyl phosphate (Sigma) in Tris (pH 
9.5), 5 mM MgCl2, 50 mM NaCl. After enzymatic development for 5-
30 min, filters were washed in PBS and dried. Control filters were 
treated identically but not UV irradiated. Positive clones were rescued 
into pBluescript II plasmids. After screening 300000 pfu from an 
unamplified library, only one full-length clone corresponding to rpr-
1 was identified. 
2.2. Sequence analysis 
Sequencing of the rpr-1 cDNA was carried out using Taq 'Dye-
deoxy'W terminator chemistry on an ABI 373A automated sequencer. 
Initial sequencing primers were complementary to the T3 and T7 sites 
on the pBluescript Vector, and subsequent ones were designed to 
match newly acquired sequence. Each part of the sequence was read 
at least once on each strand. Comparison of the sequences with the 
EMBL database was performed using the E-mail FASTA service of 
EBI (FASTA@ebi.ac.uk), while alignment and translation-by-com-
puter were performed using the SEQAID program, obtained from 
netserv@ebi.ac.uk. 
2.3. In vitro translation 
Coupled in vitro transcription and translation of rpr-1 cDNA was 
carried out in vitro using Promega's TNT®1 reticulocyte lysate system, 
using biotinylated leucine (tRNAnscend48, also from Promega) to 
label the peptides produced. Plasmids carrying luciferase cDNA 
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were used as positive controls for translation reactions. Translation 
products were analysed on 10% SDS-PAGE gels [14]. 
2.4. Expression studies 
Northern blotting was carried out by separating polyA+ RNA from 
neonatal rat tissues (2 itg/track) on a 1.2% agarose/formaldehyde gel 
and blotting it on to a HiBond N membrane (Amersham Interna-
tional). RNA was fixed to the membrane by UV irradiation (X = 254 
nm, 3 min) and baking dry at 80°C for 60 min. Non-specific binding 
sites were blocked with 50% formamide, 5X SSC, 5X Denhardts' 
solution, 100 ug/ml salmon sperm DNA, 50 ng/ml yeast tRNA, 
0.1% SDS, then the blot was hybridised with 3x 106 cpm of denatured 
rpr-1 (radiolabelled by random priming) in the same solution at 42°C 
for 40 h. After hybridisation, the filters were washed at room temper-
ature in 2X SSC (20 min) then in 2X SSC 0.2% SDS, then in 0.2% 
SSC 0.2% SDS at 65°C for 20 min. The washed filters were then 
exposed to Kodak XAR-5 film at —70°C overnight. After stripping, 
filters were rehybridised with a probe for the house-keeping gene L27 
to confirm that tracks contained an equal amount of RNA. 
In situ hybridisation was carried out using Amersham's 'RNA Col-
our Kit', but with some departures from the standard protocol pro-
vided with it. The T7 and T3 promoters were used to make fluores-
cein-labelled sense and antisense probes from linearised RTX-lOb 
cDNA, according to the protocol provided with the kit. Sprague-
Dawley rat kidneys were fixed in 10% formalin, embedded in wax 
and sectioned using standard histological procedures. They were 
then dewaxed, incubated in 0.2 M HC1 for 10 min at room temper-
ature, washed in 0.1% Triton X-100 in PBS for 1 min, rinsed in PBS 
and treated with 10 ug/ml proteinase K in PBS for 10 min at room 
temperature. They were then allowed to dry. Prior to hybridisation, 
sections were incubated for 1 h in the hybridisation mix supplied with 
the RNA Colour Kit, then hybridised with the fluorescein-labelled 
probes in hybridisation solution at 53°C overnight. The following 
day, they were washed in 2X SSC (2X 5 min, room temperature), 
in 0.2X SSC 0.1% SDS at 53°C for 10 min, rinsed in 2X SSC then 
incubated in a 1% solution of blocking agent (from the kit) for 1 h. 
Sheep antifluorescein primary antibody was diluted 1:100 in PBS and 
applied to the sections overnight at 4°C. Slides were then washed in 
PBS, and a 1:500 solution of mouse anti-alkaline phosphatase was 
applied to them for 30 min. They were again washed in PBS, and 
incubated in a 1:50 solution of anti-mouse IgG labelled with 10 nm 
gold particles for a further 30 min. The sections were then washed 
again in PBS, post-fixed in 10% formalin for 1 h, and stained with 
haematoxylin and eosin and viewed under dark-field optics. 
2.5. 3H-RTX binding to kidney sections 
Sections from the same blocks used for in situ hybridisation studies 
were dewaxed in xylene, rehydrated through graded alcohols and in-
cubated for 1 h in incubation medium (PBS containing 0.02% Triton 
X-100 and 1 mg/ml Znl2). The liquid was then shaken off the slides, 
and approximately 50 ul fresh incubation medium containing 3H-
RTX (40 uCi/ml) was placed on to the sections and incubated on 
them for 3 h at room temperature in a humidified chamber. Slides 
were washed in three changes of approximately 100 ml of incubation 
buffer, dried, coated with LM-1 nuclear emulsion (Amersham) and 
exposed for 7 days at 4°C. They were viewed on a Zeiss photomicro-
scope under dark-field illumination. Slides that had not been incu-
bated in 3H-RTX were used as controls for non-specific silver fixation 
or photoreflective effects. 
3. Results 
3.1. Sequence of rpr-1 
Clone rpr-1 was isolated from a DRG cDNA expression 
library on the basis of its ability to bind resiniferatoxin [13]. 
The base sequence of clone 10b cDNA, determined by Taq 
Dye-deoxy® chemistry, may be found in the EMBL database 
(accession number X99477). The 1728 base sequence contains 
an open reading frame of 1047 bases, commencing with an 
ATG codon at position 109, within a good Kozak consensus 
[15], and ending with a TAG termination codon at position 
1156. A consensus poly-adenylation signal, AATAAA, ap-
Fig. 1. In vitro translation of rpr-1 cDNA: a single band appears at 
the approximate predicted molecular mass of rpr-1 (arrow). 
pears downstream of the termination codon at position 
1702, and a short length of poly-A may be seen at the extreme 
3' end of the cloned cDNA. 
The only open reading frame of rpr-1 yields a 349 amino 
acid, 39 kDa peptide with no secretory leader sequence and no 
strongly hydrophobic (potentially membrane-spanning) 
stretches: it is therefore presumably cytoplasmic. To confirm 
the size of the predicted protein, the clone was transcribed and 
translated in an in vitro assay using the TNT coupled retic-
ulocyte lysate system. Only one translation product (~39 
kDa) was observed (Fig. 1). 
Comparison of the rpr-1 cDNA with the contents of the 
EMBL and Genbank databases, using the FASTA algorithm, 
reveals a close similarity (90.8% identity at the nucleic acid 
level) to the recently reported murine gene, mpr56-l [8]. The 
similarity between these two genes is even higher (92%) at the 
amino acid level (Fig. 2), and the proteins from the two spe-
cies are exactly the same length (349 amino acids). In partic-
ular, the four histidine residues (H26, H28, H201, H230) and the 
aspartate (D298) which co-ordinate with metal ions and are 
absolutely necessary for bacterial phosphotriesterase function 
[6,16], are conserved (Fig. 2). These data argue strongly that 
rpr-1 is the rat homologue of the mouse phosphotriesterase-
related gene mpr56-l. We therefore propose that it should be 
named rpr-1 (for 'rat phosphotriesterase-related gene 1', fol-
lowing the naming convention used by Hou et al. for their 
mouse phosphotriesterase-related gene, mpr56-l). 
3.2. Expression of rpr-1 
The expression pattern of rpr-1 was assessed by Northern 
blotting of tissues from new-born rats (Fig. 3). A single tran-
script, migrating at approximately 1.8 kb, was observed and 
confirmed that the cloned Kidl0b/rpr-7 cDNA was essentially 
complete. Of the organs studied (CNS, spinal ganglia, adrenal 
gland, thymus, liver, kidney, heart, lung, muscle and skin) 
only kidney produced a strong signal, with very weak signals, 
at the same molecular weight, also being apparent in the 
adrenal gland, DRG and lung tracks of over-exposed auto-
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Fig. 2. Comparison of amino acid sequences of rpr-1 (middle sequence, bold), its murine homologue, mpr56-l (bottom) and Pseudomonas phos-
photriesterase (top). Identity is indicated by ", similarity by ':' (similarity being designated as evolutionary conservative amino acid replace-
ments by the same criteria used by Hou et al. (1995) to characterise mpr56-l). The conserved histidine-26, -28, -201, -230, and aspartate-298, es-
sential for function of the bacterial enzyme (see main text), are marked with asterisks. 
radiographs. CNS, thymus, liver, heart, muscle and skin were 
negative. 
The distribution of KidlOb/rpr-7 transcripts within kidney 
was determined by in situ hybridisation (Fig. 4). Transcripts 
were detected primarily in the proximal tubule, including 
Bowman's capsule but not the vascular elements of the glo-
merulus itself. A fainter signal can also been seen in the other 
nephric epithelia, but stromal cells do not express the gene at 
detectable levels. This distribution is similar to that obtained 
by probing kidney sections with tritiated resiniferatoxin (Fig. 
4b); again, nephric epithelia bind the toxin strongly whereas 
vascular elements of the glomerulus and stroma do so hardly 
at all. 
4. Discussion 
4.1. Structure and homologies of rpr-1 
We have isolated a novel gene from rat tissues which is so 
similar to the mouse gene mpr56-l that we are confident that 
they are homologues. We therefore propose that the gene be 
called rpr-1. Despite the fact that rpr-1 was isolated from a 
resiniferatoxin-binding clone, there is also no apparent homol-
ogy between it and the previously described resiniferatoxin-
binding protein, RTX-26 [13]. 
Hou et al. [8] who isolated the murine homologue of rpr-1, 
mpr56-l, showed that its closest homology was to a set of 
microbial genes that includes Flavobacterium parathion hydro-
lase and the phosphotriesterases of E. coli and P. diminuta [3-
5]. These genes code for zinc metallo-enzymes that catalyse 

























Fig. 3. Northern blot of tissues from new-born rat probed with 
rpr-1 cDNA. 
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Fig. 4. a: In situ hybridisation of rat kidney sections probed with antisense riboprobes made from rpr-1 cDNA. A strong signal is present in 
the proximal tubules (pt), with weaker expression being seen in the other nephric epithelia. The vascular components of the glomerulus (g) 
show almost no expression, b: Kidney section probed with 3H-RTX; the toxin is bound primarily by tubular epithelia, particularly proximal 
(p), and only a little by glomeruli (g) and stroma. Scale bar: 20 urn. 
the hydrolysis of a range of phosphotriester compounds, in-
cluding the pesticides parathion and paraoxon and the neuro-
toxins sarin and soman. The degree of similarity between the 
rodent sequences and those from bacteria is very high at the 
active sites of the bacterial enzymes [6,16], strengthening the 
suggestion that mpr56-l and rpr-1 might also be phosphotries-
terases. 
The clone carrying rpr-1 was isolated by screening an ex-
pression library with resiniferatoxin. A possible explanation 
for this might be that the phosphotriesterase homologue can 
bind to the trialkoxycarbon structure found in resiniferatoxin, 
which is similar in structure to a phosphotriester but with 
carbon in place of phosphorus. We have no direct evidence 
for this, but note that one of the mammalian targets damaged 
by resiniferatoxin treatment is the kidney [17]. It is there-
fore possible that the damaging effect of the drug is me-
diated by binding to rpr-1 directly in the proximal tubules 
of the kidney, rather than purely indirectly by the neurally 
mediated effects that have been proposed to account for this 
toxicity. 
4.2. Expression 
The expression pattern of rpr-1 is intriguing. The only tissue 
to express rpr-1 at levels high enough to produce a strong 
signal on a Northern blot is kidney, specifically proximal tu-
bule epithelium. The renal expression pattern, observed in 
new-born rats, agrees generally with the expression pattern 
of mpr56-l in new-born mice, reported by Hou et al. [8] but 
unlike rats, mice also express high level of the transcript in the 
liver. There are, however, some differences in detail between 
our rat results and those obtained by Hou et al. in mice; they 
did not detect expression in lung, and we find very high rpr-1 
expression in neonatal rat kidneys whereas mpr56-l appears in 
murine kidneys only after 1 week post-partum. 
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4.3. Possible functions of rpr-1 
The most outstanding problem to be addressed in future 
work is that of the in vivo function of rpr-1. At present, the 
only clue comes from its strong homology to bacterial phos-
photriesterases, but there is not yet any experimental proof 
that rpr-1 (or mpr56-l) is itself a phosphotriesterase. Assum-
ing for the moment that it might be, what is likely to be its 
normal substrate? 
Phosphotriesters are not common substrates in biochemis-
try, but they can be produced by the action of alkylating 
agents on phosphodiester compounds. These alkylations are 
generally unwanted and may be deleterious, particularly when 
they occur in DNA. Alkylating agents such as such as ethyl 
nitrosurea are known to cause both N-alkylation and O-alky-
lation, the latter producing a phosphotriester linkage in the 
normally phosphodiester DNA 'backbone'; in the case of eth-
yl nitrosurea, more than 50% of the alkylation is of the latter 
type [18]. Bacteria such as E. coli can deal with O-alkylation 
using the Ada protein which, like phosphotriesterases, con-
tains zinc [19,20]. Mammalian cells can also deal with this 
type of DNA damage, although not particularly efficiently, 
but the enzymes responsible remain unidentified (see Ref. 
[21] for a review). Might rpr-1 might be involved in repair 
of O-alkylated DNA? If it were, then one might expect that 
the tissue that expresses it most strongly would be relatively 
immune from O-alkylating reagents, but unfortunately for 
this hypothesis rats treated with such agents show a particu-
larly high incidence of renal carcinoma [22], the precisely op-
posite result that would be expected were rpr-1 to be protec-
tive. 
Even if it does not act on DNA, a eukaryotic phosphotries-
terase might still hydrolyse small cytoplasmic molecules that 
would otherwise prove toxic; the efficiency of bacterial phos-
photriesterases in protecting mice against organophosphate 
neurotoxins demonstrates the principle well [2]. If this hypo-
thetical function proves correct, eukaryotic phosphotriester-
ases may turn out to be of great medical and economic sig-
nificance. Attempts to control the spread of insect-borne 
diseases, such as malaria, using organophosphate insecticides 
are being frustrated by the development of resistant strains of 
insects. Some of these achieve resistance by modification of 
acetylcholinesterase [23], others show a phosphotriesterase ac-
tivity apparently different from that of bacterial phosphotries-
terases [24], while others achieve resistance by unknown 
means. If rpr-1 does turn out to have the phosphotriesterase 
activity predicted from its homology, it would be very inter-
esting to establish whether insects have homologous genes and 
whether these genes might confer resistance to pesticides such 
as parathion. 
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